Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
39,365,394
-
Share change
-
-5,562,363
-
Total reported value
-
$23,615,883
-
Put/Call ratio
-
22%
-
Price per share
-
$0.60
-
Number of holders
-
77
-
Value change
-
-$3,995,490
-
Number of buys
-
35
-
Number of sells
-
49
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2024
As of 30 Jun 2024,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,365,394 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Avidity Partners Management LP, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., ORBIMED ADVISORS LLC, ACADIAN ASSET MANAGEMENT LLC, Affinity Asset Advisors, LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, and ADAR1 Capital Management, LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.